What we promise?
Product | Arformoterol D3 |
---|---|
CAT No. | CS-O-15661 |
CAS No. | 1198353-13-7 |
Status |
![]() |
Category | Stable Isotopes |
Hazardous | This is not a Hazardous Compound |
Purity | Not less than 90% |
Controlled | No |
Arformoterol D3 is a medication used for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It is a long-acting beta-adrenergic agonist that helps to relax the muscles in the airways, making it easier to breathe. Arformoterol D3 is a deuterated form of arformoterol, meaning that it contains three deuterium atoms instead of the normal hydrogen atoms. This makes it more stable and less prone to degradation in the body, which can lead to improved efficacy and reduced side effects. Chemically, arformoterol D3 is a white to off-white powder that is soluble in water. It is a selective beta-2 adrenergic agonist, which means that it primarily targets the beta-2 receptors in the lungs, leading to bronchodilation. The drug has a half-life of approximately 26 hours, meaning that it remains active in the body for an extended period of time. Arformoterol D3 is typically administered via inhalation, either through a nebulizer or a metered-dose inhaler. It is important to follow the dosage instructions provided by a healthcare professional, as overuse can lead to adverse effects such as tremors, palpitations, and increased heart rate. Patients with a history of cardiovascular disease or hypertension should exercise caution when using arformoterol D3. Overall, arformoterol D3 is an effective medication for the management of COPD and asthma. Its chemical properties make it a stable and long-lasting treatment option, providing relief for those suffering from respiratory conditions.
Packing | Product will be supplied in Vials, in certain conditions we also use 'Septa Vials' |
---|---|
Controlled | No |
Parent API | Formoterol |
Therapeutic | Anti-Asthma / COPD |
Smileys | O[C@H](C1=CC(NC=O)=C(O)C=C1)CN[C@H](C)CC2=CC=C(OC([2H])([2H])[2H])C=C2 |
Hazardous | No |
General Information | Use proper personal protective equipment |
---|---|
Handling | Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. |
Engineering Control | Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels. |
Clothing | Wear appropriate protective clothing to minimize contact with skin. |
Skin | Wear appropriate protective gloves and clothing to prevent skin exposure. |
Eyes | Wear safety glasses and chemical goggles if splashing is possible. |
Inhalation | Remove from exposure and move to fresh air immediately. |
![]() |
Arformoterol D3 | www.clearsynth.com |
CAT : CS-O-15661 | BATCH : CSC-WWW0757 |
|
MF: -- CAS: 1198353-13-7 Date of Anaysis: 22-Aug-2023 Retest Date: 22-Jun-2026 |
MW: --
Store at refrigerator (2-8C) |
Qty: 60 MG |
Only for R & D and Analytical purpose, Not for Human Consumption. |
API Standards
Stable Isotopes
Impurities
Impurities
Impurities
Impurities
API Standards
Impurities
Stable Isotopes
Impurities
Impurities
Impurities
API Standards
Stable Isotopes
Stable Isotopes
Stable Isotopes
EP Standards
API Standards
Chiral
Impurities
Impurities
Impurities
Impurities
API Standards
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Glucuronides
Stable Isotopes
Stable Isotopes
Nitrosamine
Impurities
Impurities
Glucuronides
Stable Isotopes
Need a Quote?
Your email address will not be published. Required fields are marked *